Similarly, an independent group demonstrated that a novel PDE9A inhibitor (compound C33(S)) protected rats against isoproterenol-induced cardiac hypertrophy, with treated animals displaying smaller increases in heart mass and less fibrosis compared to controls [5]. The gene discussed is PDE9A; the disease is cardiac hypertrophy.